XML 24 R13.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
SEGMENT REPORTING
3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
SEGMENT REPORTING SEGMENT REPORTING
In the first quarter of 2024, we revised our reportable segments to combine our eRad business, which was included in the Imaging Center segment, with our AI segment to form a new Digital Health reportable segment. Prior period amounts were adjusted retrospectively to reflect the change in reportable segment.

Our reportable segments are described below:
Imaging Center
Our Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services, a strategy that diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.
Digital Health
Our Digital Health segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. Included in the segment is our eRad subsidiary, which designs the underlying critical scheduling, data storage and retrieval systems necessary for imaging center operation.
Our chief operating decision maker ("CODM"), who is also our CEO, evaluates the financial performance of our segments based upon their respective revenue and segmented internal profit and loss statements prepared on a basis not consistent with GAAP. We do not report balance sheet information by segment since it is not reviewed by our CODM.
In the normal course of business, our reportable segments enter into transactions with each other. While intersegment transactions are treated like third-party transactions to determine segment performance, the revenues recognized by a segment and expenses incurred by the counterparty are eliminated in consolidation and do not affect consolidated results.
Three Months Ended March 31, 2024
Imaging Centers
Digital Health
Intersegment EliminationConsolidated Total
Revenue:
Third Party$423,209 $8,498 $— $431,707 
Intersegment— 6,163 (6,163)— 
Total revenue$423,209 $14,661 $(6,163)$431,707 
Three months ended March 31, 2023
Imaging CentersDigital HealthIntersegment EliminationConsolidated Total
Revenue:
Third Party$385,251 $5,313 $— $390,564 
Intersegment— 5,764 (5,764)— 
Total revenue$385,251 $11,077 $(5,764)$390,564 
The table below presents segment information reconciled to our financial results, with segment operating income or loss including revenue less cost of operations, depreciation and amortization, and other operating expenses to the extent specifically identified by segment (in thousands):
Three months ended March 31,
20242023
Revenue:
Imaging Centers$417,046 $379,487 
Digital Health14,661 11,077 
Total revenue$431,707 $390,564 
Cost of Operations
Imaging Centers$372,305 $340,151 
Digital Health15,284 11,714 
Total cost of operations$387,589 $351,865 
Depreciation and Amortization:
Imaging Centers$29,974 $29,448 
Digital Health2,394 1,867 
Total depreciation and amortization$32,368 $31,315 
(Gain) Loss on Disposal of Equipment:
Imaging Centers$188 $577 
Digital Health(2)
Total loss on disposal of equipment$186 $579 
Severance
Imaging Centers$225 $122 
Digital Health— 12 
Total severance$225 $134 
 Income (Loss) from Operations
Imaging Centers$14,354 $9,189 
Digital Health(3,015)(2,518)
Total income from operations$11,339 $6,671